Concepedia

Masanori Miwa

MM

Statistics

Publications

21

Citations

3.7K

H-Index

16

Active since

1980

Affiliations

Takeda (Japan)(Current)

Nippon Electric Glass (Japan)

Roche (Switzerland)

Roche (Japan)

Chugai Pharma (United States)

Masanori Miwa is an author at Takeda (Japan) specializing in pharmacology, chemotherapy, and medicinal chemistry.

Publications per year

1980–2022

21

Publications

21

A G Protein-coupled Receptor Responsive to Bile Acids

Yuji Kawamata, Ryo Fujii, Masaki Hosoya et al. · Journal of Biological Chemistry · 2003 · 1.6K citations · Full text

, , +17

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

Masanori Miwa, Masako Ura, M Nishida et al. · European Journal of Cancer · 1998 · 1.2K citations

, , +12

Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouridine.

Hideo Ishitsuka, Masanori Miwa, Kenji Takemoto et al. · PubMed · 1980 · 139 citations

, , +14

The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, Capecitabine

Nobuo Shimma, Isao UMEDA, M. Arasaki et al. · Bioorganic & Medicinal Chemistry · 2000 · 135 citations

, , +7

K-Ras(G12D)-selective inhibitory peptides generated by random peptide T7 phage display technology

Kotaro Sakamoto, Yusuke Kamada, Tomoya Sameshima et al. · Biochemical and Biophysical Research Communications · 2017 · 114 citations

, , +9

1–5 of 21